Runx2 induces bone osteolysis by transcriptional suppression of TSSC1

Biochem Biophys Res Commun. 2013 Sep 6;438(4):635-9. doi: 10.1016/j.bbrc.2013.07.131. Epub 2013 Aug 8.

Abstract

Advanced breast cancers frequently metastasize to bone, resulting in osteolytic lesions, however, the underlying mechanisms are poorly understood. Runx2, a bone-specific transcriptional factor, is abnormally expressed in highly metastatic breast cancer cells. Here, we found that TSSC1 inhibits breast cancer cell invasion. Subsequently, TSSC1 is confirmed as a target of Runx2 and is negatively regulated by Runx2. Furthermore, overexpression of Runx2 induces bone osteolysis in a TSSC1-dependent manner. Our results may provide a strategy for the treatment of breast cancer and the prevention of skeletal metastasis.

Keywords: Breast cancer; Osteolytic lesions; Runx2; TSSC1.

MeSH terms

  • Animals
  • Bone Neoplasms / genetics
  • Bone Neoplasms / metabolism
  • Bone Neoplasms / pathology
  • Bone Neoplasms / secondary*
  • Bone and Bones / metabolism
  • Bone and Bones / pathology*
  • Breast / metabolism
  • Breast / pathology
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • Mice, SCID
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology
  • Nuclear Proteins / genetics*
  • Nuclear Proteins / metabolism
  • Osteolysis*
  • Up-Regulation

Substances

  • Core Binding Factor Alpha 1 Subunit
  • EIPR1 protein, human
  • Nuclear Proteins
  • TSSC1 protein, mouse